611 W. Union Street
Benson, AZ 85602
(520) 586-0800

Health Choice Integrated Care crisis Line

NurseWise 24-Hour Crisis Line


611 W. Union Street
Benson, AZ 85602
(520) 586-0800

NurseWise 24-Hr Crisis Line


powered by centersite dot net

Getting Started
Here are some forms to get started. These can be printed and brought with you so that you can pre-fill out some known info ahead of time. More...

Basic InformationLatest News
Rydapt Approved for Adults With Acute Myeloid LeukemiaRegorafenib Approved for Hepatocellular CarcinomaStivarga Approved for Liver CancerMoney Pressures Mount When a Spouse Gets CancerGene Expression Profile Improves ID of High-Risk MelanomaFDA Warns Companies Selling Fraudulent Cancer TreatmentsCancer Risk Rises After Childhood Organ Transplant: StudyStudy Says Blood-Chromosome Test Predicts Lung Cancer's ReturnWaiting 10 Months for Colonoscopy May Raise CRC RiskFDA Warns 14 Companies on Bogus Cancer 'Cures'PSA Testing Rates for Prostate Cancer Have Leveled OffShould Prostate Cancer Screening Start Earlier for Black Men?Surveillance Biopsy Timing Not Tied to ReclassificationSecond Cancers Deadlier for Younger People: StudyHypertension May Positively Affect Ovarian Cancer PrognosisASCO Updates Recs on Potentially Curable Pancreatic CancerBreast Cancer Rates Increasing Among Asian-American WomenVaccine-Chemotherapy Combo Promising in GlioblastomaYoga Helps Ease Side Effects of Prostate Cancer TreatmentVaccine Targeting Brain Tumors Seems Safe in StudyCancer Occurrence Differs Among African-Born, U.S.-Born BlacksIt's Yoga to the Rescue for Prostate Cancer PatientsMortality Up With Depression Just Before Breast Cancer DiagnosisBlack Americans' Cancer Rates Differ by BirthplaceMetformin Use Does Not Increase Prostate Cancer SurvivalHousehold Flame Retardants Tied to Thyroid Cancer RiskMany Docs Don't Discuss Prostate Cancer Screening Pros and ConsUpdated Prostate Cancer Test Guidelines Now Stress Patient ChoiceMindfulness Practice Reduces Cortisol Blunting During ChemoCombo Rx Plus Stem-Cell Tx Ups PFS in Multiple MyelomaHealth Tip: Eat Healthy After Radiation TherapyCan Smog Raise Breast Cancer Risk?Survival Up With Surgery for Abdominal Melanoma MetastasesIncreased Cancer Risk for Childhood Kidney RecipientsSurgery May Be Best for Advanced MelanomaMany Disabled Adults Aren't Screened for Colon Cancer: Study'Cancer Profile' Is Changing for Americans With HIVAACR: Genetic Mutations Seen in Many Childhood Cancer SurvivorsProlonged Antibiotic Use Tied to Precancerous Colon GrowthsAACR: Shorter Sleep Duration Linked to Prostate CA MortalityProtein Expression Predicts Rectal Cancer OutcomesDrug Offers Some Hope for a Deadly Lung CancerAACR: Atezolizumab Aids Some With Triple-Negative Breast CAAACR: Regular Aspirin Use Linked to Lower Cancer MortalityGene Changes May Put Childhood Cancer Survivors at Risk'Electric Cap' Might Help Fight a Deadly Brain TumorBreast Cancer 'Immunotherapy' Helps Some With Tough-to-Treat DiseaseThyroid Cancer Incidence, Mortality Up in U.S. Since 1974U.S. Thyroid Cancer Cases Continue to RiseSurvival Continues to Improve for Most Cancers
LinksBook ReviewsSelf-Help Groups
Related Topics

Medical Disorders
Pain Management

Blood Test May Spot Lung Cancer's Return, Even Before Scans

HealthDay News
by -- Robert Preidt
Updated: Mar 20th 2017

new article illustration

MONDAY, March 20, 2017 (HealthDay News) -- A blood test can detect the return of lung cancer months before CT and PET scans, a new study suggests.

The research included 48 adults with stage 2 or 3 locally advanced non-small cell lung cancer (NSCLC). The patients were aged 31 to 84. All were treated with chemotherapy and radiation.

Blood samples were taken before treatment, during treatment, and at six different times during the two years following treatment. The blood samples were checked for increased levels of circulating tumor cells, the researchers said.

The blood tests were able to detect lung cancer recurrence an average of six months before CT and PET scans, the investigators found.

The study was presented March 16 at a meeting of the American Society for Radiation Oncology, in San Francisco. Research presented at meetings should be viewed as preliminary until published in a peer-reviewed journal.

"The additional lead time afforded by an earlier diagnosis may enable doctors to better tailor alternative and salvage treatments to improve their patients' outcomes and quality of life," said lead author Chimbu Chinniah. He is a research fellow in radiation oncology at the University of Pennsylvania School of Medicine in Philadelphia.

"Earlier detection of recurrence may even translate into an increased likelihood of curing these patients when their tumor burden is lowest and thus more likely to respond to therapy," Chinniah suggested in a society news release.

According to the study's senior author, Dr. Charles Simone II, "The future use of circulating tumor cells as a diagnostic and prognostic tool for localized NSCLC looks promising."

Simone said that imaging tests -- such as CT and PET scans -- will remain "the cornerstone of post-treatment surveillance."

But blood tests could be used together with imaging scans. This combination might be a better way to monitor patients after treatment, he added. Simone is an associate professor of radiation oncology at the University of Maryland School of Medicine, in Baltimore.

More information

The U.S. National Cancer Institute has more on lung cancer.